AU1375000A - Heterocyclic compounds regulating clotting - Google Patents

Heterocyclic compounds regulating clotting

Info

Publication number
AU1375000A
AU1375000A AU13750/00A AU1375000A AU1375000A AU 1375000 A AU1375000 A AU 1375000A AU 13750/00 A AU13750/00 A AU 13750/00A AU 1375000 A AU1375000 A AU 1375000A AU 1375000 A AU1375000 A AU 1375000A
Authority
AU
Australia
Prior art keywords
heterocyclic compounds
compounds regulating
clotting
regulating clotting
heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13750/00A
Inventor
Anne Marie Hornemann
Palle Jakobsen
Egon Persson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1375000A publication Critical patent/AU1375000A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13750/00A 1998-11-26 1999-11-23 Heterocyclic compounds regulating clotting Abandoned AU1375000A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA 1998-11-05
DKPA199801560 1998-11-26
PCT/DK1999/000646 WO2000030646A1 (en) 1998-11-26 1999-11-23 Heterocyclic compounds regulating clotting

Publications (1)

Publication Number Publication Date
AU1375000A true AU1375000A (en) 2000-06-13

Family

ID=8106071

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13750/00A Abandoned AU1375000A (en) 1998-11-26 1999-11-23 Heterocyclic compounds regulating clotting

Country Status (2)

Country Link
AU (1) AU1375000A (en)
WO (1) WO2000030646A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4179878B2 (en) 2001-02-02 2008-11-12 中外製薬株式会社 Peptide derivatives
EP1260817A3 (en) 2001-05-08 2002-12-18 Warner-Lambert Company Method for direct measurement of coagulation factor VIIa activity in plasma
DE60232170D1 (en) 2001-08-30 2009-06-10 Alizyme Therapeutics Ltd THIENO- (1,3) -OXAZINE-4-ONE WITH LIPASE INHIBIVING EFFECT
CN1620439A (en) 2001-12-20 2005-05-25 Osi药物公司 Pancreatic lipase inhibitor compounds, their synthesis and use
DE602004025803D1 (en) * 2003-06-06 2010-04-15 Arexis Ab USE OF CONDENSED HETEROCYCLIC COMPOUNDS AS SCCE INHIBITORS FOR THE TREATMENT OF SKIN STATE

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210669A (en) * 1983-12-27 1988-05-30 Syntex Inc Benzoxazin-4-one derivatives and pharmaceutical compositions
US4665070A (en) * 1985-06-25 1987-05-12 Syntex (U.S.A.) Inc. 2-oxy-4H-3,1-benzoxazin-4-ones and pharmaceutical use
US5652237A (en) * 1994-09-09 1997-07-29 Warner-Lambert Company 2-substituted-4H-3, 1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease for the treatment of inflammatory processes
WO1999048878A1 (en) * 1998-03-24 1999-09-30 Novo Nordisk A/S Heterocyclic compounds regulating clotting

Also Published As

Publication number Publication date
WO2000030646A1 (en) 2000-06-02

Similar Documents

Publication Publication Date Title
AU1978699A (en) Heterocyclic compounds
AU4580599A (en) Stable no-delivering compounds
AU2863899A (en) New compounds
AU4260199A (en) Novel compounds
AUPP003197A0 (en) New heterocyclic compounds
AU7907498A (en) Novel heterocyclic compounds
AU1424200A (en) Compounds
AU4501699A (en) Aminoazole compounds
AU7907298A (en) Novel heterocyclic compounds
AU2014800A (en) Novel compounds
AU2739899A (en) Well control
AU5980899A (en) Novel compounds
AU2826099A (en) Heterocyclic compounds regulating clotting
AU1434500A (en) Compounds
AU6291098A (en) Novel heterocyclic compounds
AU4814699A (en) Novel compounds
AU6059999A (en) 2-substituted heterocyclic sulfonamides
AU4167099A (en) Heterocyclic compounds as hypoglycemic agents
AU1375000A (en) Heterocyclic compounds regulating clotting
AUPO622597A0 (en) New heterocyclic compounds
AU2187799A (en) Novel taxaneterpine compounds
AUPO527597A0 (en) Novel heterocyclic compounds
AU1682400A (en) 4-oxoimidazolidine-2-spiro-nitrogenous heterocycle compounds
AU3730699A (en) Heterocyclic compound
AU1983599A (en) Oxygenic heterocyclic compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase